He Xia, Ding QiuMing
Department of Clinical Laboratory, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University, Shengzhou, 312400, China.
Heliyon. 2024 Feb 20;10(5):e26585. doi: 10.1016/j.heliyon.2024.e26585. eCollection 2024 Mar 15.
Hepatitis B virus-related decompensated cirrhosis (HBV-DC) is a critical illness with a low survival rate. Timely identification of prognostic indicators is crucial for risk stratification and personalized management of patients. The present study aimed to investigate the potential of the D-dimer-to-platelet count ratio (DPR) as a prognostic indicator for HBV-DC.
A retrospective review of medical records was conducted for 164 patients diagnosed with HBV-DC. Baseline clinical and laboratory characteristics were extracted for analysis. The endpoint was 30-day mortality. Disease severity was assessed by the Model for End-stage Liver Disease (MELD) score. A multivariate logistic regression model and receiver operating characteristic curve analysis (ROC) were used to evaluate the predictive value of DPR for mortality.
During the 30-day follow-up period, 30 (18.3%) patients died. Non-survivors exhibited significantly higher DPR values than survivors, and a high DPR had a strong association with increased mortality. Importantly, DPR was identified as an independent risk factor for mortality in HBV-DC patients after adjustments for confounding factors (Odds ratio = 1.017; 95% Confidence interval, 1.006-1.029; p = 0.003). The cut-off value of DPR as a predictor of mortality was>57.6 (sensitivity = 57%, specificity = 86%, p < 0.001). The area under ROC curve for DPR for 30-day mortality was 0.762, comparable to the MELD score (p = 0.100). Furthermore, the combined use of DPR and MELD score further increased the area under the ROC curve to 0.897.
Elevated DPR was demonstrated to have a correlation with unfavorable outcomes in HBV-DC patients, suggesting its potential utility as an effective biomarker for assessment of prognosis in these patients.
乙型肝炎病毒相关失代偿期肝硬化(HBV-DC)是一种病死率较低的危重病。及时识别预后指标对于患者的风险分层和个体化管理至关重要。本研究旨在探讨D-二聚体与血小板计数比值(DPR)作为HBV-DC预后指标的潜力。
对164例诊断为HBV-DC的患者进行病历回顾性分析。提取基线临床和实验室特征进行分析。终点为30天死亡率。采用终末期肝病模型(MELD)评分评估疾病严重程度。采用多因素逻辑回归模型和受试者工作特征曲线分析(ROC)评估DPR对死亡率的预测价值。
在30天随访期内,30例(18.3%)患者死亡。非存活者的DPR值显著高于存活者,高DPR与死亡率增加密切相关。重要的是,在调整混杂因素后,DPR被确定为HBV-DC患者死亡的独立危险因素(比值比=1.017;95%置信区间,1.006-1.029;P=0.003)。DPR作为死亡率预测指标的截断值>57.6(敏感性=57%,特异性=86%,P<0.001)。DPR预测30天死亡率的ROC曲线下面积为0.762,与MELD评分相当(P=0.100)。此外,DPR与MELD评分联合使用可进一步将ROC曲线下面积提高至0.897。
DPR升高与HBV-DC患者不良预后相关,提示其可能作为评估这些患者预后的有效生物标志物。